164 related articles for article (PubMed ID: 32166512)
1. Quantitative imaging of the receptor for advanced glycation end-products in prostate cancer.
Konopka CJ; Woźniak M; Hedhli J; Siekierzycka A; Skokowski J; Pęksa R; Matuszewski M; Munirathinam G; Kajdacsy-Balla A; Dobrucki IT; Kalinowski L; Dobrucki LW
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2562-2576. PubMed ID: 32166512
[TBL] [Abstract][Full Text] [Related]
2. Multimodal imaging of the receptor for advanced glycation end-products with molecularly targeted nanoparticles.
Konopka CJ; Wozniak M; Hedhli J; Ploska A; Schwartz-Duval A; Siekierzycka A; Pan D; Munirathinam G; Dobrucki IT; Kalinowski L; Dobrucki LW
Theranostics; 2018; 8(18):5012-5024. PubMed ID: 30429883
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease.
Woźniak M; Konopka CJ; Płoska A; Hedhli J; Siekierzycka A; Banach M; Bartoszewski R; Dobrucki LW; Kalinowski L; Dobrucki IT
Cell Mol Biol Lett; 2021 Mar; 26(1):10. PubMed ID: 33726678
[TBL] [Abstract][Full Text] [Related]
5. Preparation of
Wang Y; Shao G; Wu J; Cui C; Zang S; Qiu F; Jia R; Wang Z; Wang F
Contrast Media Mol Imaging; 2018; 2018():8046541. PubMed ID: 29853810
[TBL] [Abstract][Full Text] [Related]
6. Targeted nanoparticles for multimodal imaging of the receptor for advanced glycation end-products.
Drake LR; Scott PJH
Theranostics; 2018; 8(22):6352-6354. PubMed ID: 30613302
[TBL] [Abstract][Full Text] [Related]
7. Targeting receptor for advanced glycation end products (RAGE) expression induces apoptosis and inhibits prostate tumor growth.
Elangovan I; Thirugnanam S; Chen A; Zheng G; Bosland MC; Kajdacsy-Balla A; Gnanasekar M
Biochem Biophys Res Commun; 2012 Jan; 417(4):1133-8. PubMed ID: 22206663
[TBL] [Abstract][Full Text] [Related]
8. The advanced glycation end-product N
Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
10. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
11. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
12. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
13. Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
Touijer KA; Michaud L; Alvarez HAV; Gopalan A; Kossatz S; Gonen M; Beattie B; Sandler I; Lyaschenko S; Eastham JA; Scardino PT; Hricak H; Weber WA
Eur Urol Oncol; 2019 Mar; 2(2):166-173. PubMed ID: 31017093
[TBL] [Abstract][Full Text] [Related]
14. Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer.
Nedrow JR; Latoche JD; Day KE; Modi J; Ganguly T; Zeng D; Kurland BF; Berkman CE; Anderson CJ
Mol Imaging Biol; 2016 Jun; 18(3):402-10. PubMed ID: 26552656
[TBL] [Abstract][Full Text] [Related]
15. Preclinical efficacy of hK2 targeted [
Timmermand OV; Elgqvist J; Beattie KA; Örbom A; Larsson E; Eriksson SE; Thorek DLJ; Beattie BJ; Tran TA; Ulmert D; Strand SE
Theranostics; 2019; 9(8):2129-2142. PubMed ID: 31149033
[TBL] [Abstract][Full Text] [Related]
16. RAGE-specific single chain Fv for PET imaging of pancreatic cancer.
Kim HY; Wang X; Kang R; Tang D; Boone BA; Zeh HJ; Lotze MT; Edwards WB
PLoS One; 2018; 13(3):e0192821. PubMed ID: 29529089
[TBL] [Abstract][Full Text] [Related]
17. Single-photon emission computed tomography/computed tomography imaging of RAGE in smoking-induced lung injury.
Goldklang MP; Tekabe Y; Zelonina T; Trischler J; Xiao R; Stearns K; Rodriguez K; Shields A; Romanov A; D'Armiento JM; Johnson LL
Respir Res; 2019 Jun; 20(1):116. PubMed ID: 31182072
[TBL] [Abstract][Full Text] [Related]
18. A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.
Ganguly T; Dannoon S; Hopkins MR; Murphy S; Cahaya H; Blecha JE; Jivan S; Drake CR; Barinka C; Jones EF; VanBrocklin HF; Berkman CE
Nucl Med Biol; 2015 Oct; 42(10):780-7. PubMed ID: 26169882
[TBL] [Abstract][Full Text] [Related]
19. Increased Prostate Cancer Glucose Metabolism Detected by
Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F
Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897
[TBL] [Abstract][Full Text] [Related]
20. Possible role of the receptor of advanced glycation end products (RAGE) in the clinical course of prostate neoplasia in patients with and without type 2 diabetes mellitus.
Akkus G; Izol V; Ok F; Evran M; Inceman M; Erdogan S; Kaplan HM; Sert M; Tetiker T
Int J Clin Pract; 2021 Mar; 75(3):e13723. PubMed ID: 32957168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
